NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe

J Magn Reson Imaging. 2009 Dec;30(6):1357-63. doi: 10.1002/jmri.22021.

Abstract

In this article we summarize recommendations and guidelines for the prevention of NSF from the United States, Canada, and Europe. J. Magn. Reson. Imaging 2009;30:1357-1363. (c) 2009 Wiley-Liss, Inc.

Publication types

  • Review

MeSH terms

  • Canada
  • Contrast Media / administration & dosage
  • Dose-Response Relationship, Drug
  • Europe
  • Gadolinium / administration & dosage
  • Gadolinium / adverse effects*
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Nephrogenic Fibrosing Dermopathy / chemically induced*
  • Nephrogenic Fibrosing Dermopathy / prevention & control*
  • Practice Guidelines as Topic*
  • Renal Insufficiency / complications
  • Renal Insufficiency / diagnosis*
  • United States

Substances

  • Contrast Media
  • Gadolinium